top of page

Corporate Governance

SEC Filing

Notice and proxy statement for extraordinary general meeting

BOARD OF DIRECTORS

Ilan-483.1.jpg

ILAN LEVIN

Chairman and Chief Executive Officer

1591218400250.jpg

MICHAEL BASCH

Director

  • Over 15 years of entrepreneurship and venture capital experience

  • Managing Partner at Atento Capital

  • Consultant at George Kaiser Family Foundation

  • Board Member at Sway Medical and i2E, Inc.

1523464251393.jpg

ERIC BRACHFELD

Director

  • Over 30 years of investment banking experience

  • Founder and Managing Partner of Manhattan Venture Partners (MVP) – focusing on the secondary market for late-stage, venture-backed pre-IPO companies

  • Previously served as a Partner at Citizen VC and was a Co-Founder at Gentry New York.

craigmarshak.jpg

CRAIG J. MARSHAK

Vice Chairman and Co Founder

  • 25 years of investment banking, private equity and venture capital experience

  • Managing Director at Israel Venture Partners

  • Previously Managing Director and Global Co-Head of Nomura Technology Investment Growth Fund, Director at Schroders and Morgan Stanley

1516202163640.jpg

RUTH ALON

Director

 

  • Over 25 years of venture capital experience, serving as General Partner with Pitango Venture Capital

  • Previously held positions with Montgomery Securities and Kidder Peabody & Co., as a medical device analyst

  • Board member at Vascular Biogenics (NASDAQ: VBLT) and Anchiano Therapeutics (NASDAQ: ANCN)

bottom of page